USPTO 2015–2025 USPTO PatentsView US Corporation

Second Sight Medical Products, Inc.

USPTO PatentsView assignee record - 135 granted patents across 29 technology areas, active 2015–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

135

Total patents granted

CPC technology areas

12.2

Avg claims per patent

-82%

5-year filing velocity

The verdict

Second holds 135 US patents across 29 technology areas, rank #2,853 of 50,000 tracked assignees.

#2,853
of 50,000 US assignees by volume: Top 24%
by Innovation Score (44.9/100): 12.2
avg claims per patent: -82%
filing velocity, last 5 yrs

Portfolio overview

Second Sight Medical Products, Inc. has been granted 135 US utility patents between 2015 and 2024, placing Second Sight Medical Products, Inc. at rank #2,853 across all assignees tracked by PlainPatent. This portfolio spans 29 distinct Cooperative Patent Classification (CPC) subclasses, averaging 12.2 claims per patent with primary concentration in A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY). As a US Corporation, Second Sight Medical Products, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Second sits between RH US, Llc (135 patents, rank #2,849) and Bruker Nano, Inc. (134 patents, rank #2,857) - the closest US assignees by grant volume. The composite Innovation Score of 44.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 21 grants, compared with 114 in the 2015–2019 window, a -82% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Second Sight Medical Products, Inc.'s 12.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 29 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Second Sight Medical Products, Inc. against peers pursuing similar technology classes.

RH US

135
Sanechips Technol…

135
Spine WAVE

135
Suntory Flowers

135
Tamura

135
Toagosei

135
Warner Bros Enter…

135
Second Sight Medi… ◀

135
Bruker Nano

134

What this shows Second holds 135 patents at rank #2,853, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Second

By rank, the assignees closest to #2,853 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Second's primary technology class.

Second's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

45 Top 24% higher than 76% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Second Sight Medical Products, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	30	22.2%
2016	23	17.0%
2017	24	17.8%
2018	27	20.0%
2019	10	7.4%
2020	9	6.7%
2021	6	4.4%
2022	5	3.7%
2024	1	0.7%

Which technologies does Second Sight Medical Products, Inc. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 124

H05K - PRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS 31

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 20

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 20

G06V - IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING 15

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 15

H01L - SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10 12

G09B - EDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS 6

C23C - COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL 6

C25D - PROCESSES FOR THE ELECTROLYTIC OR ELECTROPHORETIC PRODUCTION OF COATINGS; ELECTROFORMING; APPARATUS THEREFOR 5

G06T - IMAGE DATA PROCESSING OR GENERATION, IN GENERAL 5

B32B - LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM 4

F04C - ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS ; ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT PUMPS 2

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 2

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 2

Top 15 of 29 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Multi-domain

Claim Depth Standard

Velocity Declining

Where it ranks

Overall rank by patents

#2,853

Across all tracked assignees

Innovation Score

44.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Second Sight Medical Products, Inc. hold?

Second Sight Medical Products, Inc. holds 135 US granted patents filed between 2015 and 2024, spanning 29 technology areas.

What is Second Sight Medical Products, Inc.'s Innovation Score?

Second Sight Medical Products, Inc. has an Innovation Score of 44.9 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Second Sight Medical Products, Inc. focus on?

Second Sight Medical Products, Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY) with 124 patents. The company has filed patents in 29 CPC subclasses total.

Is Second Sight Medical Products, Inc.'s patent filing rate increasing or decreasing?

Second Sight Medical Products, Inc.'s recent filing velocity is -82% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for Second Sight Medical Products, Inc.'s patents?

Second Sight Medical Products, Inc.'s patents average 12.2 claims each. This falls within the standard range, providing solid legal coverage.

How is the Second Sight Medical Products, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Second's 135 grants land it in the top 24% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Second ranks #2,853 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61N - see who else leads that technology area. A61N leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.